Case Report
J Clin Exp Oncol
Influence of Abemaciclib, a New CDK 4/6 Inhibitor, Decrease in Potassium Electrollytes and Urea in a Patient Suffering from Metastatic Breast Cancer

Article(s) in May Issue
Journal of Clinical & Experimental Oncology received 2848 citations as per Google Scholar report